4/A//SEC Filing
Easom Eric 4/A
Accession 0001610717-24-000191
CIK 0001880438other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 4:16 PM ET
Size
24.8 KB
Accession
0001610717-24-000191
Insider Transaction Report
Form 4/AAmended
Easom Eric
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2024-03-15+99,000→ 101,130 total
Footnotes (1)
- [F1]Previously reported on a Form 4 filed on March 18, 2024. As amended, the vesting schedule for the restricted stock units is as follows: 1/4th of the shares vests annually over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001914503
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 4:16 PM ET
- Size
- 24.8 KB